Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
Qian J, Betensky RA, Hyman BT, Serrano-Pozo A.
Neurology. 2021 Mar 26. PMID: 33771840
Links
Bibliography
Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement.
Palma JA, Vernetti PM, Perez MA, Krismer F, Seppi K, Fanciulli A, Singer W, Low P, Biaggioni I, Norcliffe-Kaufmann L, Pellecchia MT, Martí MJ, Kim HJ, Merello M, Stankovic I, Poewe W, Betensky R, Wenning G, Kaufmann H.
Clin Auton Res. 2021 Apr. 31(2):157-164. PMID: 33554315
Displaying survival of patient groups defined by covariate paths: Extensions of the Kaplan-Meier estimator.
Jay M, Betensky RA.
Stat Med. 2021 Apr 15. 40(8):2024-2036. PMID: 33530128
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.
Young TK, Shaw KS, Shah JK, Noor A, Alperin RA, Ratner AJ, Orlow SJ, Betensky RA, Shust GF, Kahn PJ, Oza VS.
JAMA Dermatol. 2021 02 01. 157(2):207-212. PMID: 33295957
A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.
DesRuisseaux LA, Williams VJ, McManus AJ, Gupta AS, Carlyle BC, Azami H, Gerber JA, Bolling AM, Cook CL, Betensky RA, Arnold SE.
Trials. 2020 Dec 11. 21(1):1016. PMID: 33308285
Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation.
Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, Buckley RF.
Neurology. 2021 01 26. 96(4):e619-e631. PMID: 33199430
Accounting for incomplete testing in the estimation of epidemic parameters.
Betensky RA, Feng Y.
Int J Epidemiol. 2020 10 01. 49(5):1419-1426. PMID: 32734290
Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults.
Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJ.
Mol Psychiatry. 2020 Oct. 25(10):2644. PMID: 30538309
Exchanging Dermatoscopes for Stethoscopes: Has the COVID-19 Pandemic Highlighted Gaps in US Dermatology Residency Training?
Shaw KS, Karagounis TK, Yin L, Svigos K, Gibbon GT, Betensky RA, Lo Sicco KI.
J Drugs Dermatol. 2020 Sep 01. 19(9):905-906. PMID: 33026742
Response to "Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment".
Shaw KS, Karagounis TK, Yin L, Gibbon G, Betensky RA, Lo Sicco KI, Femia AN.
J Am Acad Dermatol. 2020 Aug 07. PMID: 32777319
News
HSPH’s Joseph Brain ends 40-year stretch teaching Harvard undergrad public health course
Joseph Brain, Cecil K. and Philip Drinker Professor of Environmental Physiology at Harvard School of Public Health, launched the Harvard undergraduate course “The Human Organism” in 1971 and has taught it for all but one year since. He…
Predicting survival for brain cancer patients
Is it possible to predict survival for patients with oligodendroglioma from aberrations in their DNA? According to a 2006 study by Rebecca Betensky and colleagues, the answer is yes. An analysis of DNA in 93 patients was completed…
Projecting MS progression
To help physicians predict the likelihood that a patient’s multiple sclerosis will advance significantly in the near term, Rebecca Betensky and her collaborators have developed a formula, which they continue to refine. Using data from a small…
The oddsmaker
[ Spring 2008 ] A math whiz takes on brain cancer, MS, and Alzheimer’s disease. Rebecca Betensky’s dad worked as a statistician for a global oil company on “credit rating stuff,” she says, so for a long time, she “stayed…
